UPDATE: Cowen Downgrades Nektar Therapeutics (NKTR) to Market Perform
Tweet Send to a Friend
(Updated - March 14, 2022 4:20 PM EDT)
Cowen analyst Chris Shibutani downgraded Nektar Therapeutics (NASDAQ: NKTR) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen analyst Chris Shibutani downgraded Nektar Therapeutics (NASDAQ: NKTR) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
